We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 16 SEPTEMBER 2015
High Court upholds finding that Crestor patent is invalid

Corrs Chambers Westgarth
Contributor

Corrs Chambers Westgarth
Corrs Chambers Westgarth is Australia’s leading independent law firm. We provide exceptional legal...
View firm profileThe Court held that an AstraZeneca patent relating to the blockbuster statin drug CRESTOR (rosuvastatin) was invalid.
AustraliaIntellectual Property






